A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Koruk et al 17 Prospective randomized trial comparing dexmedetomidine–ketamine with midazolam-ketamine in 50 pediatric patients for extracorporeal shock wave lithotripsy Sedation was equally ...

This article provides a descriptive account of the reports from the literature regarding the use of a combination of dexmedetomidine and ketamine for procedural sedation. Data Source: A ...

According to the United States Drug Enforcement Administration (DEA), ketamine is a “dissociative anesthetic that has some hallucinogenic effects” and “can induce a state of sedation ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...